Betaxolol HCl Ophthalmic Solution Rx
Generic Name and Formulations:
Betaxolol HCl 0.5%; oph soln; contains benzalkonium chloride.
Indications for Betaxolol HCl Ophthalmic Solution:
Open-angle glaucoma. Ocular hypertension.
1–2 drops in affected eye(s) twice daily. Concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted if needed.
Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.
History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. Asthma. Pulmonary impairment. Diabetes (esp. labile). May mask hypoglycemia and hyperthyroidism. May potentiate muscle weakness. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.
May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics.
Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.
Formerly known under the brand name Betoptic.
Soln—5mL, 10mL, 15mL
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses
- Autism Spectrum Disorders Associated With Depression in Young Adults
- Gestational Diabetes Associated With Increased Risk for Postpartum Depression
- Combination Cognitive Behavioral Therapy With Fluoxetine Effective for Adolescent Depression
- Smartphone-Based Psychoeducational Programs May Be Effective for Bipolar Disorder Management